UCB and Cancer Research UK form expanded alliance to advance novel cancer therapies
Partnership builds on existing collaboration and adds two new UCB‑nominated projects
Read More
Author: John Pinching
Calla Lily Clinical Care begins dosing in trial of intravaginal platform for threatened miscarriage
Nihr‑funded phase 2 study to assess progesterone delivery using Callavid device
Read More
Virendra Shelar
Omron has appointed Virendra Shelar as CEO of Omron Europe
Read More
Palisade Bio reports phase 1a/b data showing colon‑targeted exposure
Findings support once‑daily dosing and reinforce PALI‑2108’s potential
Read More- UCB and Cancer Research UK form expanded alliance to advance novel cancer therapies
- Calla Lily Clinical Care begins dosing in trial of intravaginal platform for threatened miscarriage
- Palisade Bio reports phase 1a/b data showing colon‑targeted exposure
- MimiVax and Roswell Park open phase 2 trial of SurVaxM for metastatic neuroendocrine tumours
- Myomaker Bio unveils lab‑grown human muscle platform to transform drug testing
